He Eye Specialist Hospital

What He Eye Specialist Hospital does

He Eye Specialist Hospital Group (何氏眼科集团, listed entity Liaoning He Shi Eye Hospital Group Co., Ltd., Shenzhen Stock Exchange 301103) is a vertically integrated Chinese ophthalmology platform founded in 1995 by Dr. He Wei in Shenyang. The group operates a direct network of at least 13 hospital branches across Liaoning, Beijing, and Chongqing, complemented by a franchise channel, a three-tier city-county-township cloud medical platform, and an international training footprint spanning Asia, Africa, and Latin America. Its service portfolio spans refractive cataract surgery, myopia/refractive surgery, myopia prevention and control, medical optometry, diabetic eye disease, dry eye and corneal disease, genetic diagnosis, comprehensive eye disease, and full-lifecycle eye health management.

The technology layer combines AI-assisted diagnostic imaging, computer-vision-enabled intelligent slit lamp devices for township-level screening, cloud-based electronic health records, big-data analytics over roughly 500,000 child myopia screening records, and a gene technology platform built around the 2017 Eye Gene Bank in partnership with BGI Genomics. The 365 Myopia Prevention and Control Model (2025 Edition) functions as a structured digital program linking school, family, and clinical settings, while the He Vision Smart City strategy positions the group as a full-lifecycle eye-health ecosystem. Proprietary R&D outputs include Dr. He Wei's portfolio of nearly 60 patents and the in-house developed Juming Granules TCM formulation for dry eye, produced through the He Eye Industry Base (Shenyang Qipanshan Science and Technology City, est. 2009).

Revenue is generated across four streams: clinical ophthalmology services across the hospital network (refractive cataract, myopia surgery, myopia control, corneal/retinal/glaucoma treatment, optical fitting), education services through Liaoning He Shi Medical College (national second-tier private university), R&D licensing and ophthalmic product/device sales from the He Eye Industry Base, and optical retail through He Shi Glasses Co., Ltd. (notably orthokeratology lenses). Strategic device partnerships with Johnson & Johnson Vision and Zeiss China Medical anchor premium surgical capability, while a poverty-alleviation partnership with SDIC/China State Investment Group supports free surgery and screening programs in underserved counties across Guizhou, Hebei, Henan, Anhui, Gansu, and Yunnan. Customer segments span general population across all life stages, with primary focus on children/adolescents for myopia prevention and elderly patients for cataract and glaucoma, plus underserved populations served through the three-tier blindness prevention model.

Name

He Eye Specialist Hospital

Legal name

沈阳何氏眼科医院有限公司

Website

https://hsyk.com.cn

Company type

Public

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

He Eye Specialist Hospital is a publicly listed Chinese ophthalmology group operating 13 hospital branches plus a franchise channel, a medical college, and an R&D industry base, delivering AI-enabled, gene-informed eye care from myopia prevention to cataract surgery across China and in international training programs.

Ownership category

akta.pro rank

Product category

Ophthalmology Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Optometrists (62132), Optical Goods Retailers (45613), Diagnostic Imaging Centers (621512)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011), Ophthalmic Goods (3851)

akta.pro primary industry

Ophthalmic Specialty Hospitals (HLAFAHAJ)

akta.pro secondary industries

Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Glaucoma Specialists (HLAKAKAG), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN), Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE), Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

Keywords

• Ophthalmology services
• Refractive cataract surgery
• Myopia prevention control
• Medical optometry fitting
• Genetic eye diagnosis

Headquarters

HQ city

Shenyang

HQ country

China

HQ region

Asia

Offices13 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Medical Services (Ophthalmology Hospital Operations): Revenue from providing comprehensive ophthalmology medical services including refractive surgery, cataract treatment, myopia control, cornea treatment, retinal diseases, glaucoma treatment, and optical配镜 services across their hospital network.
2. Education Services: Revenue from Liaoning He Shi Medical College (辽宁何氏医学院), a national second-tier university providing medical education and training programs.
3. R&D and Technology Licensing: Revenue from eye industry base (何氏眼产业基地) developing ophthalmic drugs, surgical consumables, and medical equipment, plus patent licensing.
4. Optical Products and Medical Devices: Revenue from He Shi Glasses Co., Ltd. (沈阳何氏眼镜有限公司) providing optical products and orthokeratology lenses.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

He Eye Specialist Hospital operates a technology-driven, integrated ophthalmology platform that delivers clinical eye care across nine service lines — refractive cataract surgery, myopia/refractive surgery, myopia prevention and control, medical optometry and lens fitting, diabetic eye disease, dry eye and corneal disease, genetic diagnosis, and comprehensive eye disease (strabismus/amblyopia, glaucoma, visual psychology, integrated Chinese-Western medicine) — supported by the proprietary 365 Myopia Prevention & Control Model, a three-tier cloud medical platform for remote diagnosis, AI-powered slit-lamp screening devices, gene diagnostics, and big-data analytics. The group ties healthcare delivery to medical education (Liaoning He Shi Medical College), R&D and ophthalmic product manufacturing (He Eye Industry Base), and an optical retail arm (He Shi Glasses Co., Ltd.) to provide full-lifecycle eye health management from childhood myopia prevention through geriatric cataract and chronic disease treatment.

Product overview

He Eye Specialist Hospital (何氏眼科集团) operates as a technology-driven, integrated eye health platform offering a comprehensive ecosystem of ophthalmic healthcare services, medical education, R&D, and industry operations. The core service portfolio spans nine major clinical service lines: refractive cataract surgery, myopia/refractive surgery, myopia prevention and control, medical optometry, diabetic eye disease, dry eye and corneal disease, genetic diagnosis, comprehensive eye disease care, and full-lifecycle eye health management. The company operates the '365 Myopia Prevention and Control Model' as a structured digital platform that coordinates school-family-clinical institution linkages, and the overarching 'He Vision Smart City' (智慧光明城) ecosystem strategy that unifies medical services, education (辽宁何氏医学院), research (何氏眼产业基地), and industry under one umbrella. Services are delivered through a three-tier hierarchical healthcare model (city-county-township) and supported by proprietary cloud medical platforms, AI-assisted diagnostic tools, and genetic testing capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• 365近视防控模式: A comprehensive myopia prevention and control model launched in 2025, integrating three scenarios, six core technologies, and five management systems.
• 视界之光
• 何氏·菁英汇
• 何氏智慧光明城

Products and services

• Refractive Cataract Surgery (屈光白内障) Advanced cataract surgery that combines refractive correction technology with premium intraocular lens implantation, simultaneously removing the cataract and correcting pre-existing refractive errors to deliver high-quality visual outcomes for patients.
• Myopia/Refractive Surgery (近视手术) Laser and surgical procedures such as LASIK for correcting myopia and other refractive errors, reducing or eliminating patient dependence on corrective eyewear.
• Myopia Prevention & Control (近视防控) Comprehensive myopia prevention and control services that integrate genetic testing, optical interventions, behavioral modification, and big-data monitoring for children and adolescents across school, home, and clinical settings.
• Medical Optometry and Lens Fitting (医学验配) Professional optometric services including prescription of corrective lenses, orthokeratology (OK) lens fitting, and specialized optical device dispensing based on comprehensive eye examinations.
• Diabetic Eye Disease Treatment (糖尿病眼病) Specialized diagnosis and treatment of diabetic retinopathy and other ocular complications of diabetes mellitus, including anti-VEGF injections and laser photocoagulation therapies.
• Dry Eye & Corneal Disease Treatment (干眼及角膜) Diagnosis and treatment services for dry eye syndrome and corneal disorders, including the company's self-developed "Juming Granules" (菊明颗粒) TCM formulation, in addition to advanced diagnostic and therapeutic interventions.
• Genetic Diagnosis (基因诊断) Ophthalmic genetic testing and precision medicine services leveraging gene-detection technology to identify hereditary eye-disease risk factors, myopia susceptibility genes, and pathogenic mutations for conditions such as retinitis pigmentosa.
• Comprehensive Eye Disease Care (综合眼病) Full-spectrum ophthalmic care covering strabismus and amblyopia, glaucoma, visual psychology, and integrated Chinese-Western medicine treatment approaches.
• 365 Myopia Prevention & Control Model (365近视防控模式) A standardized digital myopia prevention and control management system with three major scenario linkages (school, family, professional institution), six core technologies (genetics, environment, medicine & optics, eye load, behavior, nutrition), and five management systems (warning assessment, personalized control, high myopia management, complication treatment, smart eye health management).
• He Vision Smart City (何氏智慧光明城) Full-lifecycle eye health smart industry ecosystem integrating medical, educational, industrial, and research operations, built on big data, AI, gene technology, and stem cell platforms to enable intelligent, precise, and inclusive eye health management across all life stages.
• Three-Tier Eye Health Medical Service Model (三级眼健康医疗服务模式) Hierarchical healthcare delivery model organized across city-county-township levels, with provincial-level centers providing advanced care, county-level hospitals handling intermediate cases, and township/village clinics delivering primary prevention and screening services.
• Full Lifecycle Eye Health Management (全生命周期眼健康管理) Continuous eye health management services spanning from infancy through old age, covering preventive care, early detection, treatment, and rehabilitation across all stages of human development.
• Orthokeratology (OK) Lens (角膜塑形镜) Specially designed rigid gas-permeable contact lens worn overnight to temporarily reshape the cornea, providing clear daytime vision without glasses while slowing myopia progression in children and adolescents.

Quantifiable outcome

• 30 million+ people served through three-tier blindness prevention model
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Johnson & Johnson Vision (强生眼力健)coreStrategic or Co-development Partner · 6 September 2025Strategic partnership升级 to establish 'Presbyopia Diagnosis and Treatment Center Strategic Cooperation Group' and 'Refractive Cataract Global Innovation Technology Strategic Cooperation Group'. The partnership aims to build a precise refractive diagnosis and treatment full-chain platform, leveraging Johnson & Johnson's Catalys白力士 femtosecond laser system and premium IOL products.
• Zeiss China Medical (蔡司中国医疗)coreStrategic or Co-development Partner · 6 September 2025Established six specialized technical cooperation units including: High Myopia Cataract Surgery Cooperation Unit, High Myopia & Presbyopia Surgery Cooperation Unit, Presbyopia Correction IOL Surgery Cooperation Unit, Astigmatism Correction IOL Surgery Cooperation Unit, Digital Precision Refractive Cataract & Presbyopia Surgery Cooperation Unit, and Zero-energy Nucleus Breaking - Cataract Surgery Innovation Technology Cooperation Unit.
• National Government/State-owned Assets Investment (国投集团)coreStrategic or Co-development PartnerPartnership with SDIC (State Development & Investment Corp) through Central Poverty Alleviation Fund to implement 'Precision Medical Care • Precision Poverty Alleviation' programs in poverty-stricken counties across multiple provinces including Guizhou, Hebei, Henan, Anhui, Gansu, and Yunnan.
• Cameroon Yaoundé Optometry Technology MOCI WorkshopminorStrategic or Co-development PartnerInternational training workshop in Cameroon providing optometry technology training to ophthalmologists and optometrists from 13 countries, part of the company's global outreach program.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• C-MER Eye Care Holdings: Hong Kong-listed Chinese ophthalmology chain with a national network of hospitals. Comparable in scale and listing status; competes for premium cataract and refractive surgery patients and physician talent.
• Huaxia Eye Hospital Group: Another major Chinese specialty ophthalmology hospital chain competing head-to-head in cataract, refractive surgery, and myopia control. Highly comparable in service mix and operating model to He Eye Specialist Hospital.
• Aier Eye Hospital Group: China's largest listed ophthalmology chain (Shenzhen: 300015) operating 800+ centers across Asia, Europe, and the US. Direct competitor across cataract, refractive, and optometry services; He Group is dwarfed in scale but pursues a more tech- and training-centric model.
• Zhongshan Ophthalmic Center (Sun Yat-sen University): Leading academic ophthalmology center in South China, strong in cataract, glaucoma, and genetic eye disease research. Competes for complex cases and top physician talent, particularly in southern China where He Group is underweight.
• Beijing Tongren Hospital: Capital Medical University's flagship ophthalmology specialty hospital and one of China's most prestigious eye-care institutions. Competes in tertiary ophthalmology, complex surgery, and academic/clinical research; sets the clinical benchmark He Group benchmarks against.

Broad incumbents

• Johnson & Johnson Vision: Global leader in contact lenses, IOLs, and femtosecond cataract systems (Catalys). Strategic partner with He Group for refractive cataract and presbyopia; defines the technology envelope for premium ophthalmic surgery.
• Alcon: Global ophthalmic devices, surgical, and vision care company; competes in the same IOL, cataract, and refractive surgery supply ecosystem that He Group's premium service lines depend on.
• Carl Zeiss Meditec: Global leader in ophthalmic surgical microscopes, IOLs, and diagnostic equipment. A partner of He Group's six specialized cooperation units and a broad incumbent whose products and platforms are foundational to the refractive cataract and presbyopia market He Group is targeting.

Emerging players

• BGI Genomics: China's largest genomics company and strategic partner with He Group on ophthalmic gene diagnostics and the Eye Gene Bank. Comparable as an emerging player in genomic-driven precision ophthalmology, with shared investment in genetic risk profiling for eye disease.

Regional players

• Oasis Healthcare Group: Asia-focused ophthalmology chain with presence in China, Hong Kong, and Southeast Asia. Comparable as a regional specialty eye hospital group targeting premium refractive and cataract markets, though with less national density than He Group.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about He Eye Specialist Hospital